Literature DB >> 18079707

Induction of pluripotent stem cells from fibroblast cultures.

Kazutoshi Takahashi1, Keisuke Okita, Masato Nakagawa, Shinya Yamanaka.   

Abstract

Clinical application of embryonic stem (ES) cells faces difficulties regarding use of embryos, as well as tissue rejection after implantation. One way to circumvent these issues is to generate pluripotent stem cells directly from somatic cells. Somatic cells can be reprogrammed to an embryonic-like state by the injection of a nucleus into an enucleated oocyte or by fusion with ES cells. However, little is known about the mechanisms underlying these processes. We have recently shown that the combination of four transcription factors can generate ES-like pluripotent stem cells directly from mouse fibroblast cultures. The cells, named induced pluripotent stem (iPS) cells, can be differentiated into three germ layers and committed to chimeric mice. Here we describe detailed methods and tips for the generation of iPS cells.

Entities:  

Mesh:

Year:  2007        PMID: 18079707     DOI: 10.1038/nprot.2007.418

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  378 in total

1.  myc maintains embryonic stem cell pluripotency and self-renewal.

Authors:  Natalia V Varlakhanova; Rebecca F Cotterman; Wilhelmine N deVries; Judy Morgan; Leah Rae Donahue; Stephen Murray; Barbara B Knowles; Paul S Knoepfler
Journal:  Differentiation       Date:  2010-05-27       Impact factor: 3.880

2.  Diagnosis in a dish: your skin can help your brain.

Authors:  Anita Huttner; Pasko Rakic
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

3.  Production of mice using iPS cells and tetraploid complementation.

Authors:  Xiao-Yang Zhao; Zhuo Lv; Wei Li; Fanyi Zeng; Qi Zhou
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

Review 4.  Somatic cell nuclear transfer: origins, the present position and future opportunities.

Authors:  Ian Wilmut; Yu Bai; Jane Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

5.  Molecular cloning and production of caprine recombinant Oct4 protein for generation induced pluripotent stem cells.

Authors:  Dinesh K Singhal; Raxita Singhal; Hruda N Malik; Surender Singh; Sudarshan Kumar; Jai K Kaushik; Ashok K Mohanty; Dhruba Malakar
Journal:  Mol Biol Rep       Date:  2015-10-30       Impact factor: 2.316

6.  Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.

Authors:  Gwanghyun Jung; Giovanni Fajardo; Alexandre J S Ribeiro; Kristina Bezold Kooiker; Michael Coronado; Mingming Zhao; Dong-Qing Hu; Sushma Reddy; Kazuki Kodo; Krishna Sriram; Paul A Insel; Joseph C Wu; Beth L Pruitt; Daniel Bernstein
Journal:  FASEB J       Date:  2015-12-16       Impact factor: 5.191

7.  Induced Pluripotent Stem Cell Labeling Using Quantum Dots.

Authors:  Hiroshi Yukawa; Kaoru Suzuki; Yuki Kano; Tatsuya Yamada; Noritada Kaji; Tetsuya Ishikawa; Yoshinobu Baba
Journal:  Cell Med       Date:  2013-10-29

Review 8.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

9.  Cellular reprogramming dynamics follow a simple 1D reaction coordinate.

Authors:  Sai Teja Pusuluri; Alex H Lang; Pankaj Mehta; Horacio E Castillo
Journal:  Phys Biol       Date:  2017-12-06       Impact factor: 2.583

10.  Generation of a Functional Human Neural Network by NDM29 Overexpression in Neuroblastoma Cancer Cells.

Authors:  Susanna Alloisio; Patrizia Garbati; Federica Viti; Silvia Dante; Raffaella Barbieri; Giovanni Arnaldi; Alessia Petrelli; Arianna Gigoni; Paolo Giannoni; Rodolfo Quarto; Mario Nobile; Massimo Vassalli; Aldo Pagano
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.